Good response to cyclosporine therapy in patients with myelodysplastic syndrromes having the HLA-DRB1*1501 allele
Authors:
- 25 January 2000
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 14 (2) , 344-346
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrowBritish Journal of Haematology, 1998
- Antithymocyte globulin for patients with myelodysplastic syndromeBritish Journal of Haematology, 1997
- Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemiaBlood, 1994
- Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individualsTissue Antigens, 1994
- Successful treatment of refractory anemia with high‐dose methylprednisoloneAmerican Journal of Hematology, 1990